Search

everythinglearnresearchcommunity

for

Search:↓

ASLAN004 was safe and well-tolerated, supporting further development for treating certain diseases.

Researchers created specific antibodies that detect a protein important in development and various conditions, and can be used for research and diagnosis.

BKN-1 antibody targets specific keratin in basal cell epithelioma and normal skin basal cells.

Antibody treatments show promise for hair loss but need more research.

Adalimumab significantly improved symptoms and quality of life in two patients with Hidradenitis Suppurativa.

Antihepcidin antibodies may treat inflammation-induced anemia by improving iron metabolism.

PROTACs offer a new, precise way to treat cancer by breaking down harmful proteins.

HSA nanoparticles can improve tamoxifen delivery for breast cancer treatment, reducing side effects.

IMG-007 helps regrow hair and reduce scalp inflammation in severe alopecia areata.

Combining cell conditioning with mild protease digestion effectively shows versican mRNA in mouse skin sections.

TH antibodies in vitiligo and AA patients recognize the same protein parts.

The study developed a mouse model for Alopecia Areata that responds to treatment, useful for future research.

The mutant HR bmh protein mis-localizes in cells, affecting skin and hair development.

Immunochemotherapy successfully treated neutropenia in a patient with Waldenström's macroglobulinemia.

A mycobacterial protein shares a similar region with a human skin protein, possibly affecting skin diseases.

CAR-T cell therapy shows promise for treating autoimmune disorders but faces challenges like complex manufacturing and limited tissue penetration.

Sex hormone antibodies can help identify male and female contributors in forensic samples.

Ostrich antibodies are a promising, cost-effective treatment for various skin diseases and conditions.

Immunoadsorption successfully treated a man's resistant polymyositis.

Adalimumab helped control a child's severe eye disease when other treatments failed.

HAT-MSCs can effectively engulf harmful microbes and particles, aiding infection treatment.

Adalimumab significantly improved Hidradenitis Suppurativa and quality of life in two patients.

Human TMEM2 does not break down hyaluronan but helps control its metabolism.

Near-infrared probes can safely and effectively image cysteine protease activity for disease diagnosis.

Newly designed proteins can effectively degrade specific proteins in cells, offering a potential new therapy method.

Modified HDL can better deliver drugs and genes, potentially improving treatments and reducing side effects.

HPDAlR nanoparticles greatly improve skin wound healing without toxicity.